Try It Now
Overview
Qure.ai is an Indian AI radiology company specializing in automated analysis of chest X-rays, CT scans, and other medical imaging for disease detection. Founded in Mumbai in 2016, Qure.ai has become one of the world's leading medical imaging AI companies, with its products deployed in over 50 countries. The company is particularly recognized for its work in tuberculosis detection and global health — its AI has screened millions of patients in resource-limited settings where radiologist access is scarce.
Qure.ai's qXR (chest X-ray AI) can detect 28+ abnormalities including tuberculosis, pneumonia, COVID-19, lung cancer, and pleural effusion from a standard chest X-ray in seconds. This capability is transformative in low-resource settings where a single radiologist may be responsible for thousands of patients — AI triage enables limited radiologist time to be focused on highest-priority cases.
In 2026, Qure.ai has expanded to include brain CT analysis (for stroke, hemorrhage), cardiac CT, and mammography AI. The company has received FDA clearance and CE marking for multiple products and partners with WHO, USAID, and major global health organizations on TB elimination programs.
Key Features
Chest X-ray AI (qXR)
Analyzes chest X-rays to detect 28+ findings including TB, pneumonia, lung cancer, COVID-19, cardiomegaly, and pleural effusion. Results in seconds.
TB Detection Specialist
World-class tuberculosis detection AI, validated across diverse populations. Key tool in WHO's TB elimination program across high-burden countries.
Brain CT Analysis
Detects stroke, hemorrhage, and other neurological emergencies from CT scans. Prioritizes urgent cases for immediate radiologist review.
AI Triage System
Automatically prioritizes scan queue by finding severity, enabling radiologists to see the most urgent cases first. Reduces time to treatment for critical patients.
Low-Resource Settings Design
Optimized for deployment in facilities with limited infrastructure. Works with standard X-ray machines and internet-connected tablets.
Population Health Screening
Mass screening programs for TB, lung cancer, and cardiac disease. Efficient analysis of large screening cohorts at population scale.
Pros & Cons
Advantages
- World-leading TB detection AI
- 50+ country deployment (proven at scale)
- FDA cleared and CE marked
- Critical for global health applications
- Low-resource environment compatibility
- Strong academic validation record
Disadvantages
- Radiology-focused (not general clinical AI)
- Deployment in high-resource settings competes with established PACS vendors
- Requires radiologist oversight for final reporting
- Some products still awaiting regulatory clearance in certain markets
Pricing Plans
| Plan | Price | Users | Key Features |
|---|---|---|---|
| Enterprise | Custom | Hospital/health system | Hospital and health system contracts |
| Global Health | Custom | NGO/Government | NGO/government pricing available |
| API | Custom | Developers | For health tech integrations |
Best Use Cases
Qure.ai Excels At:
- TB screening programs in high-burden countries
- Emergency radiology triage (stroke, hemorrhage)
- Chest X-ray analysis at scale
- Population health screening programs
- Under-resourced hospitals needing AI radiology support
May Not Be Ideal For:
- General clinical AI assistance
- Non-imaging medical applications
- Small clinics without radiology workflow
How It Compares
Qure.ai vs Aidoc
Aidoc focuses on emergency radiology AI in high-resource hospital settings. Qure.ai covers both high-resource and low-resource settings with particular strength in TB and global health applications.
Qure.ai vs Nuance/Microsoft
Nuance AI focuses on clinical documentation and speech recognition. Qure.ai focuses on medical imaging analysis. Different and complementary capabilities.
Final Verdict
Our Recommendation
Qure.ai represents AI at its most impactful — technology that saves lives in settings where conventional healthcare infrastructure is insufficient. Its TB detection AI has screened millions of patients across 50+ countries, contributing measurably to global TB elimination efforts. In high-resource settings, its emergency radiology triage capabilities improve response times for stroke and hemorrhage. The combination of clinical validation, regulatory clearance, and proven global deployment makes Qure.ai one of the most consequential medical AI companies operating today.